Display options
Cite
Clark MA, Duhay FG, Thompson AK, et al. Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients. Risk Manag Healthc Policy. 2012;5:117-26doi: 10.2147/RMHP.S34587.
Clark, M. A., Duhay, F. G., Thompson, A. K., Keyes, M. J., Svensson, L. G., Bonow, R. O., Stockwell, B. T., & Cohen, D. J. (2012). Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients. Risk management and healthcare policy, 5117-26. https://doi.org/10.2147/RMHP.S34587
Clark, Mary Ann, et al. "Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients." Risk management and healthcare policy vol. 5 (2012): 117-26. doi: https://doi.org/10.2147/RMHP.S34587
Clark MA, Duhay FG, Thompson AK, Keyes MJ, Svensson LG, Bonow RO, Stockwell BT, Cohen DJ. Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients. Risk Manag Healthc Policy. 2012;5:117-26. doi: 10.2147/RMHP.S34587. Epub 2012 Oct 31. PMID: 23152716; PMCID: PMC3496980.
Copy Download .nbib Format: NLM
Share it on

Risk Manag Healthc Policy. 2012;5:117-26. doi: 10.2147/RMHP.S34587. Epub 2012 Oct 31.

Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients.

Risk management and healthcare policy

Mary Ann Clark, Francis G Duhay, Ann K Thompson, Michelle J Keyes, Lars G Svensson, Robert O Bonow, Benjamin T Stockwell, David J Cohen

Affiliations

  1. The Neocure Group LLC, Washington, DC.

PMID: 23152716 PMCID: PMC3496980 DOI: 10.2147/RMHP.S34587

Abstract

BACKGROUND: Aortic valve replacement (AVR) is the standard of care for patients with severe, symptomatic aortic stenosis who are suitable surgical candidates, benefiting both non-high-risk and high-risk patients. The purpose of this study was to report long-term medical resource use and costs for patients following AVR and validate our assumption that high-risk patients have worse outcomes and are more costly than non-high-risk patients in this population.

METHODS: Patients with aortic stenosis who underwent AVR were identified in the 2003 Medicare 5% Standard Analytic Files and tracked over 5 years to measure clinical outcomes, medical resource use, and costs. An approximation to the logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation) based on administrative data was used to assess surgical risk, with a computed logistic EuroSCORE > 20% considered high-risk.

RESULTS: We identified 1474 patients with aortic stenosis who underwent AVR, of whom 1222 (82.9%) were non-high-risk and 252 (17.1%) were high-risk. Among those who were non-high-risk, the mean age was 73.3 years, 464 (38.2%) were women, and the mean logistic EuroSCORE was 7%, whereas in those who were high-risk, the mean age was 77.6 years, 134 (52.8%) were women, and the mean logistic EuroSCORE was 37%. All-cause mortality was 33.2% for non-high-risk and 66.7% for high-risk patients at 5 years. Over this time period, non-high-risk patients experienced an average of 3.9 inpatient hospitalizations and total costs of $106,277 per patient versus 4.7 hospitalizations and total costs of $144,183 for high-risk patients.

CONCLUSION: Among elderly patients undergoing AVR, long-term mortality and costs are substantially greater for high-risk than for non-high-risk individuals. These findings indicate that further research is needed to understand whether newer approaches to aortic valve replacement such as transcatheter AVR may be a lower cost, clinically valuable alternative.

Keywords: aortic valve; health economics; replacement

References

  1. Health Care Financ Rev. 2004 Summer;25(4):119-41 - PubMed
  2. N Engl J Med. 2010 Oct 21;363(17):1597-607 - PubMed
  3. Circulation. 2010 Apr 6;121(13):1502-9 - PubMed
  4. Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):533-9 - PubMed
  5. Circulation. 1981 Aug;64(2 Pt 2):II184-8 - PubMed
  6. Circulation. 1982 Nov;66(5):1105-10 - PubMed
  7. Eur J Cardiothorac Surg. 2006 Nov;30(5):722-7 - PubMed
  8. Circulation. 1997 May 20;95(10):2395-400 - PubMed
  9. Circulation. 2012 Mar 6;125(9):1102-9 - PubMed
  10. Circulation. 2000 Nov 7;102(19 Suppl 3):III70-4 - PubMed
  11. N Engl J Med. 2011 Jun 9;364(23):2187-98 - PubMed
  12. Heart. 1999 Aug;82(2):143-8 - PubMed
  13. J Am Coll Cardiol. 2000 Mar 1;35(3):747-56 - PubMed
  14. Circulation. 1978 Aug;58(2):255-64 - PubMed
  15. Eur J Cardiothorac Surg. 2010 Jun;37(6):1304-10 - PubMed
  16. Eur J Vasc Endovasc Surg. 2010 Apr;39(4):403-9 - PubMed
  17. N Engl J Med. 1994 Jan 6;330(1):1-6 - PubMed
  18. Circulation. 1990 Jul;82(1):124-39 - PubMed

Publication Types